Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 764 people who get email alerts on ALNY.

Get email alerts on ALNY »

Market Currents

Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European...

Tuesday, January 25, 2011, 12:15 PM ET
Alnylam Pharma (ALNY +3.2%) gets a positive opinion for Orphan Drug Designation from European Medicines Agency for its ALN-TTR01, an RNAi therapeutic. (PR)

This Market Current was sent to 764 people who get email alerts on ALNY.

Get email alerts on ALNY »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

Latest Articles

Forbes Has It Wrong On Buffett
3:25 PM • Tim McAleenan Jr.
Raising A Yellow Flag Over REIT Valuation
3:23 PM • Adam Aloisi
Expanding Economy? Consider Adding Copper To Your Portfolio
3:12 PM • Christopher F. Davis
Why These 3 Oil Stocks Are Too Cheap To Ignore
3:06 PM • Trade In Mexico
Benjamin Graham's Rules For The Common Stock Component: Ford Motor Company
2:53 PM • Jarrod W. Jacinth
Microsoft Finally Gets How To Grow Windows Phone
2:50 PM • Tom Luongo
Markets Dance As Bernanke 'Makes It Rain'
2:48 PM • Keith Springer
And Gas Prices Roar Back
2:46 PM • Hale Stewart
Long And Bumpy Road Ahead For Tesla
2:43 PM • StockRiters
The Game Is Changing For Chinese Internet Stocks
2:34 PM • BubbleBustInvesting
Total's Bright Future: Opportunities Abound
2:30 PM • Philippe Casey
Physical Gold Market Feeding Off Paper Market Selling
2:27 PM • Hard Assets Investor
These Recent Events Confirm Nokia Could Trade Above $4
2:24 PM • Chris Lau
New Ireland Fund A Buy After Ryanair Earnings
2:23 PM • Richard Cox
Tumblr: Weighing Yahoo's Acquisition
2:14 PM • Nathaniel Matherson

More Latest Articles »